The preliminary results of the analysis of leukemia morbidity in the sub-cohort of workers from PA "Mayak" exposed with high (more than 4Gy) doses during relatively short time range (few years) have been obtained in terms of materials from the medical-dosimetry register (SUrIBPh). The earlier dynamics of the leukemia morbidity implementation (2-5 years after the beginning of exposure) was established for this sub-cohort, in contrast to that predicted on the base of examination of the cohort of atomic bombardment victims from Japan cities (LSS). The "'early" leukemia effect is connected with intensive cell death and has a threshold nature. It could be supposed, that intensification of born-marrow hematopoetics restricts a potential of reparation processes and leads to earlier (in contrast with that observed in the LSS cohort) implementation of carcinogenetic effect. Using propositions developed to describe the process of the creation of consecutive specific stable mutation in the target cells, the options is proposed of multistage model, which allows the prediction of post-radiation dynamics of leukemia morbidity intensity. Both data from LSS(DS86) and from the register for workers from PA "Mayak" were used to asses the model parameters. The satisfactory agreement is illustrated between the observed dynamics of leukemia morbidity and the model calculations.

Download full-text PDF

Source

Publication Analysis

Top Keywords

leukemia morbidity
16
dynamics leukemia
12
workers "mayak"
8
leukemia
5
[early leukemia
4
leukemia chronic
4
chronic exposure
4
exposure radiation
4
radiation high
4
high doses]
4

Similar Publications

Background: We aimed to identify the central lifestyle, the most impactful among lifestyle factor clusters; the central health outcome, the most impactful among health outcome clusters; and the bridge lifestyle, the most strongly connected to health outcome clusters, across 29 countries to optimise resource allocation for local holistic health improvements.

Methods: From July 2020 to August 2021, we surveyed 16 461 adults across 29 countries who self-reported changes in 18 lifestyle factors and 13 health outcomes due to the pandemic. Three networks were generated by network analysis for each country: lifestyle, health outcome, and bridge networks.

View Article and Find Full Text PDF

Background: Rising nosocomial infections pose high risks, especially for immunocompromised leukemia patients, necessitating targeted research to enhance patient care and outcomes.The objective of this study was to investigate the impact of nosocomial infections (CDI) on patients hospitalized with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).

Methods: Our study was a retrospective analysis of adult patients hospitalized with a primary diagnosis of ALL or AML, using the Nationwide Inpatient Sample (NIS) database for 2020.

View Article and Find Full Text PDF

To Cut (Minimally Invasively) Is to Cure: Robotic Lobectomy for Pulmonary Mucormycosis.

Ann Thorac Surg Short Rep

December 2024

Division of Cardiothoracic Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama.

Pulmonary mucormycosis is a rapidly progressive and highly morbid disease commonly found in immunosuppressed patients. Rapid diagnosis and treatment are essential, with thoracotomy and video-assisted thoracoscopic surgery techniques previously described for surgical resection of infected lobes. Here we present the case of a patient with acute myeloid leukemia and nonresolving pneumonia treated with robotic left upper lobectomy.

View Article and Find Full Text PDF

Background: Exposure to per- and polyfluoroalkyl substances (PFAS) has been linked with various cancers. Assessment of PFAS in drinking water and cancers can help inform biomonitoring and prevention efforts.

Objective: To screen for incident cancer (2016-2021) and assess associations with PFAS contamination in drinking water in the US.

View Article and Find Full Text PDF

Background: Thrombopoietin receptor agonists (TPO-RAs) have demonstrated efficacy in treating clinically significant thrombocytopenia, including chemotherapy-induced thrombocytopenia in adults. However, data regarding their safety and efficacy in pediatric, adolescents, and young adult (AYA) patients with hematologic malignancies are limited.

Methods: We retrospectively identified 15 pediatric and AYA patients aged 25 years or younger with hematologic malignancies treated with a TPO-RA at UCSF Benioff Children's Hospitals between 2015 and 2023.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!